Predictions
Crossject S.A.
Start price
Target price
Perf. (%)
€2.82
18.11.21
18.11.21
€2.50
18.11.22
18.11.22
66.84%
16.08.22
16.08.22
Could be worthwhile Investment >10% per year
Atossa Genetics Inc
Start price
Target price
Perf. (%)
€3.50
26.07.21
26.07.21
-
26.07.22
26.07.22
-74.03%
27.07.22
27.07.22
Probably not worthwhile Investment
Tabula Rasa HealthCare Inc
Start price
Target price
Perf. (%)
€4.02
21.07.22
21.07.22
-
21.07.23
21.07.23
0.50%
23.07.22
23.07.22
Allied Healthcare Products Inc
Start price
Target price
Perf. (%)
€5.75
14.07.21
14.07.21
-
14.07.22
14.07.22
-68.30%
15.07.22
15.07.22
Could be worthwhile Investment >10% per year
Alpha Pro Tech Ltd.
Start price
Target price
Perf. (%)
€6.22
11.07.21
11.07.21
€12.00
11.07.22
11.07.22
-30.03%
12.07.22
12.07.22
Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Small cyclical dependencies
Undervalued
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.24
24.06.22
24.06.22
€5.00
24.06.23
24.06.23
-1.57%
26.06.22
26.06.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.77
10.06.22
10.06.22
€0.20
10.06.23
10.06.23
24.58%
26.06.22
26.06.22
Valuable balance sheet
Probably not worthwhile Investment
very negative Cash Flow expected
Junk rating
Sernova Corp.
Start price
Target price
Perf. (%)
€0.87
13.10.21
13.10.21
€10.00
13.10.24
13.10.24
-4.83%
15.06.22
15.06.22
Leading role in innovation
Capable Management
Good culture
Strong uniques
Sernova Corp.
Start price
Target price
Perf. (%)
€0.90
13.10.21
13.10.21
€9.20
13.10.24
13.10.24
5.06%
14.06.22
14.06.22
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Undervalued
Very positive Cash Flow expected
Sernova Corp.
Start price
Target price
Perf. (%)
€0.88
13.10.21
13.10.21
€7.00
13.10.22
13.10.22
7.44%
14.06.22
14.06.22
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Rising EBIT margin expected
EBIT growth > 30% per year expected
HTG Molecular Diagnostics Inc.
Start price
Target price
Perf. (%)
€49.68
13.06.21
13.06.21
-
13.06.22
13.06.22
-88.16%
14.06.22
14.06.22
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.24
29.05.22
29.05.22
-
29.05.23
29.05.23
71.13%
09.06.22
09.06.22
Could be very worthwhile Investment >20% year
Newegg Commerce Inc.
Start price
Target price
Perf. (%)
€5.95
02.05.22
02.05.22
€12.00
02.05.23
02.05.23
-25.71%
16.05.22
16.05.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.29
01.05.22
01.05.22
-
01.05.23
01.05.23
-2.33%
14.05.22
14.05.22
Could be very worthwhile Investment >20% year
Newegg Commerce Inc.
Start price
Target price
Perf. (%)
€5.95
19.04.22
19.04.22
€11.00
19.04.23
19.04.23
0.00%
02.05.22
02.05.22
Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.59
18.04.22
18.04.22
-
18.04.23
18.04.23
-18.84%
30.04.22
30.04.22
Risky Investment
Newegg Commerce Inc.
Start price
Target price
Perf. (%)
€6.20
05.04.22
05.04.22
€11.50
05.04.23
05.04.23
-4.03%
19.04.22
19.04.22
Could be very worthwhile Investment >20% year